Thrivent Financial for Lutherans’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $383K | Buy |
14,977
+38
| +0.3% | +$972 | ﹤0.01% | 2240 |
|
2025
Q1 | $319K | Sell |
14,939
-4,076
| -21% | -$87K | ﹤0.01% | 2209 |
|
2024
Q4 | $399K | Sell |
19,015
-1,776
| -9% | -$37.3K | ﹤0.01% | 2334 |
|
2024
Q3 | $468K | Buy |
20,791
+3,907
| +23% | +$87.9K | ﹤0.01% | 2268 |
|
2024
Q2 | $283K | Sell |
16,884
-760
| -4% | -$12.7K | ﹤0.01% | 2419 |
|
2024
Q1 | $228K | Sell |
17,644
-479
| -3% | -$6.19K | ﹤0.01% | 2440 |
|
2023
Q4 | $210K | Sell |
18,123
-482
| -3% | -$5.59K | ﹤0.01% | 2421 |
|
2023
Q3 | $238K | Sell |
18,605
-851
| -4% | -$10.9K | ﹤0.01% | 2357 |
|
2023
Q2 | $267K | Sell |
19,456
-699
| -3% | -$9.59K | ﹤0.01% | 2350 |
|
2023
Q1 | $309K | Sell |
20,155
-707
| -3% | -$10.8K | ﹤0.01% | 2282 |
|
2022
Q4 | $280K | Sell |
20,862
-162
| -0.8% | -$2.17K | ﹤0.01% | 2276 |
|
2022
Q3 | $279K | Buy |
21,024
+1,043
| +5% | +$13.8K | ﹤0.01% | 2250 |
|
2022
Q2 | $382K | Buy |
19,981
+3,424
| +21% | +$65.5K | ﹤0.01% | 2192 |
|
2022
Q1 | $330K | Buy |
16,557
+6
| +0% | +$120 | ﹤0.01% | 2326 |
|
2021
Q4 | $338K | Buy |
16,551
+112
| +0.7% | +$2.29K | ﹤0.01% | 2297 |
|
2021
Q3 | $354K | Sell |
16,439
-187
| -1% | -$4.03K | ﹤0.01% | 2278 |
|
2021
Q2 | $480K | Sell |
16,626
-40
| -0.2% | -$1.16K | ﹤0.01% | 2195 |
|
2021
Q1 | $407K | Sell |
16,666
-157
| -0.9% | -$3.83K | ﹤0.01% | 2299 |
|
2020
Q4 | $327K | Hold |
16,823
| – | – | ﹤0.01% | 2270 |
|
2020
Q3 | $293K | Sell |
16,823
-158
| -0.9% | -$2.75K | ﹤0.01% | 2190 |
|
2020
Q2 | $446K | Sell |
16,981
-22
| -0.1% | -$578 | ﹤0.01% | 1961 |
|
2020
Q1 | $411K | Sell |
17,003
-3,318
| -16% | -$80.2K | ﹤0.01% | 1823 |
|
2019
Q4 | $505K | Sell |
20,321
-137
| -0.7% | -$3.41K | ﹤0.01% | 1888 |
|
2019
Q3 | $436K | Buy |
20,458
+359
| +2% | +$7.65K | ﹤0.01% | 1908 |
|
2019
Q2 | $639K | Buy |
20,099
+4,671
| +30% | +$149K | ﹤0.01% | 1677 |
|
2019
Q1 | $509K | Buy |
15,428
+1,255
| +9% | +$41.4K | ﹤0.01% | 1798 |
|
2018
Q4 | $456K | Buy |
14,173
+311
| +2% | +$10K | ﹤0.01% | 1626 |
|
2018
Q3 | $595K | Buy |
13,862
+273
| +2% | +$11.7K | ﹤0.01% | 1595 |
|
2018
Q2 | $626K | Buy |
13,589
+998
| +8% | +$46K | ﹤0.01% | 1552 |
|
2018
Q1 | $500K | Buy |
12,591
+645
| +5% | +$25.6K | ﹤0.01% | 1645 |
|
2017
Q4 | $400K | Buy |
11,946
+236
| +2% | +$7.9K | ﹤0.01% | 1783 |
|
2017
Q3 | $434K | Buy |
11,710
+400
| +4% | +$14.8K | ﹤0.01% | 1644 |
|
2017
Q2 | $419K | Buy |
11,310
+840
| +8% | +$31.1K | ﹤0.01% | 1603 |
|
2017
Q1 | $294K | Buy |
10,470
+570
| +6% | +$16K | ﹤0.01% | 1753 |
|
2016
Q4 | $290K | Buy |
9,900
+410
| +4% | +$12K | ﹤0.01% | 1730 |
|
2016
Q3 | $258K | Buy |
+9,490
| New | +$258K | ﹤0.01% | 1760 |
|
2016
Q2 | – | Sell |
-8,430
| Closed | -$228K | – | 2040 |
|
2016
Q1 | $228K | Buy |
8,430
+590
| +8% | +$16K | ﹤0.01% | 1718 |
|
2015
Q4 | $236K | Buy |
+7,840
| New | +$236K | ﹤0.01% | 1689 |
|